Skip to main content
logo
General Biologicals Corporation (TPEX:4117)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.35
-0.10 (-0.87%)
Mar 6, 2026, 12:40 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Medical Technology
70.24M158.27M129.73M182.85M138.70M
Medical Technology Growth
-55.62%22.00%-29.05%31.83%22.64%
Adjustment and Elimination
-8.12M-60.29M-44.57M-27.44M-27.03M
Diagnostic Reagents
155.46M132.69M258.54M396.24M364.20M
Diagnostic Reagents Growth
17.16%-48.68%-34.75%8.80%168.54%
Protein New Drug
34.34M34.14M26.76M--
Protein New Drug Growth
0.57%27.60%---
Total
251.93M264.83M370.46M551.66M475.87M
Total Growth
-4.87%-28.51%-32.85%15.93%98.57%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
America
---151.84M128.11M
America Growth
---18.52%133.41%
Asia and Others (Apart from Taiwan)
---223.98M220.02M
Asia and Others (Apart from Taiwan) Growth
---1.80%307.42%
Taiwan
93.78M174.86M228.94M189.23M148.51M
Taiwan Growth
-46.37%-23.62%20.99%27.41%19.18%
Europe
1.77M1.80M3.58M4.97M4.56M
Europe Growth
-1.83%-49.71%-27.92%8.88%-30.70%
Asia (Regions outside Taiwan)
29.38M42.62M55.51M--
Asia (Regions outside Taiwan) Growth
-31.07%-23.23%---
North America
126.71M42.69M77.11M--
North America Growth
196.82%-44.64%---
Other
296.00K2.86M5.32M--
Other Growth
-89.64%-46.31%---
Africa
---9.08M2.42M
Africa Growth
---275.87%-72.04%
Internal Department Transaction Revenue
----27.44M-27.75M
Total
251.93M264.83M370.46M551.66M475.87M
Total Growth
-4.87%-28.51%-32.85%15.93%98.57%
Source: S&P Global Market Intelligence.